Largon

   
Google
 
Web NewDrugInformation.com

Largon


Drug - Largon
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Propiomazine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 20MG/ML
The potency of the active ingredient(s), Propiomazine Hydrochloride. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE CORP
The firm name holding legal responsibility for Largon. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012382
The FDA assigned number to Largon. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Largon. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Largon was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Largon. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Largon is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp Anesthesia Critical Care
The full name of the firm holding legal responsibility for the new application of Largon.

Largon